Elsevier’s ClinicalPath is now a Recognized Quality Solution for the ASCO Certified Program

Elsevier today announced that ClinicalPath, its oncology decision support solution, has been designated a Recognized Quality Solution (RQS) by the Association for Clinical Oncology for the ASCO Certifiedopens in new tab/window program, reinforcing its role in advancing high-quality, patient-centered cancer care.

Omry Bigger, President, Clinical Solutions, Elsevier said “Cancer practices want to deliver the best care possible, and this recognition means they can be even more confident in the value ClinicalPath provides. Being able to support cancer practices with their reporting requirements is a crucial element of the RQS designation, and we look forward to taking this step forward with our customers.”

Clifford A. Hudis, MD, FACP, FASCO, CEO of ASCO said, "We are pleased to designate Elsevier's ClinicalPath as a Recognized Quality Solution. ClinicalPath underwent a rigorous validation process that reviewed the necessary data elements for clinical quality measurement and pathway utilization. This recognition demonstrates Elsevier's commitment to assisting practices with meeting certification requirements."

With ClinicalPath, cancer centers can:

• Deliver consistent high-quality, patient-centered care aligned with ASCO Certified standards

• Leverage evidence-based pathways driven by the latest research, updated content, and integrated clinical trials

• Streamline quality reporting and compliance with automated capture of pathway utilization and on/off pathway data

• Enhance credibility and align with payers through support for value-based care models

You can find out more about ClinicalPath here.

About ASCO Certified

ASCO Certified is a practice certification demonstrating oncology patient-centered care based on the Oncology Medical Home (OMH) Standards from the American Society of Clinical Oncology and the Community Oncology Alliance (COA)opens in new tab/window. These standards aim to establish core elements needed to deliver high-quality cancer care and achieve broad consensus among all stakeholders on what patients with cancer should expect and receive from their cancer care teams.

關於 Elsevier

身為科學資訊與分析的全球領導者，Elsevier 協助研究人員與醫療照護專業人員推動科學發展，改善醫療成果，造福社會。我們以可信賴、以實證為基礎的內容和先進的 AI 數位技術為基礎，透過創新的解決方案促進洞察力和關鍵決策。

140 多年來，我們一直為研究和醫療保健界的工作提供支援。我們全球 9,500 名員工，包括 2,300 名技術人員，致力於支援研究人員、圖書館館長、學術領袖、資金提供者、政府、研發密集型公司、醫生、護士、未來醫療保健專業人員和教育工作者的重要工作。我們的 2,900 種科學期刊和經典參考工具書包括其領域中最重要的書籍，包括 Cell Press、The Lancet 和 Gray's Anatomy。 我們與愛思唯爾基金會 (Elsevier Foundationopens in new tab/window) 合作，與我們服務的社群攜手合作，在發展中國家和世界各地的科學、研究和醫療保健領域推動包容性和多樣性。 Elsevier 是 RELXopens in new tab/window 的一部分，RELXopens in new tab/window 是一家為專業和商業客戶提供以資訊為基礎的分析和決策工具的全球供應商。有關我們的工作、數位解決方案和內容的更多資訊，請造訪 www.elsevier.com 。